<--- Back to Details
First PageDocument Content
Transport / Celestial navigation / Viking ships / Viking / Cardinal direction / Dead reckoning / Sunstone / Baltic Sea / Compass / Navigation / Watercraft / Water
Date: 2008-03-20 04:07:18
Transport
Celestial navigation
Viking ships
Viking
Cardinal direction
Dead reckoning
Sunstone
Baltic Sea
Compass
Navigation
Watercraft
Water

Add to Reading List

Source URL: sms.zrc-sazu.si

Download Document from Source Website

File Size: 739,25 KB

Share Document on Facebook

Similar Documents

VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 Basel (Switzerland) and Mannheim (Germany), July 12, 2016 – VAXIMM AG, a Swiss/German biotech company focused on develo

VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 Basel (Switzerland) and Mannheim (Germany), July 12, 2016 – VAXIMM AG, a Swiss/German biotech company focused on develo

DocID: 1rgZo - View Document

PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today a

PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today a

DocID: 1oWNB - View Document

PDF Document

DocID: 1nuIr - View Document

   	
   Introducing	
  the	
  NVPI	
  	
   	
  –	
  Nordic	
  Venture	
  Performance	
  Index	
  2014	
   Nordic	
  Venture	
  Capital	
  has	
  created	
  	
  

    Introducing  the  NVPI      –  Nordic  Venture  Performance  Index  2014   Nordic  Venture  Capital  has  created    

DocID: 1mFbl - View Document

Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology  Partnership aims to advance development of novel immune checkpoint

Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology  Partnership aims to advance development of novel immune checkpoint

DocID: 1mqfS - View Document